PIP-2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PIP-2, covering 2025-08-15 to 2025-08-15. Get the full timeline:
Most recent: Clinical Trial Update: Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be Monitored for: 1) Immune Cell Activation 2) Blood-based Biomarkers. In Vitro Models Derived From These Samples Will be Treated With Novel Agent PIP-2 to Evaluate Its Efficacy.